Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methyl iodide | HCID 6328 | — |
| Reactant | Sodium Methoxide | HCID 10942334 | — |
| Reactant | HCID 12581860 | HCID 12581860 | — |
| Reactant | HCID 12703381 | HCID 12703381 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | HCID 12848219 | HCID 12848219 | — |
| Product | HCID 178421795 | HCID 178421795 | — |
Reaction Steps
The starting material, thieno[3,4-b][1,5]benzoxazepin-10(9H)-one (I) or 7-methyl-thieno[3,4-b][1,5]benzoxazepin-10(9H)-one (II) in ethanol is treated with sodium methoxide and methyl iodide and extracted with methylene chloride to yield 9-methyl-thieno[3,4-b][1,5]benzoxazepin-10(9H)-one (III) and 7,9-dimethyl-thieno[3,4][1,5]benzoxazepin-10(9H)-one (IV) respectively. The above compounds III and IV are refluxed with 5 N sodium hydroxide for 16 hours, diluted with water, adjusted to pH 4-5 with hydrochloric acid and extracted with methylene chloride. The base compounds thus obtained are dissolved in ether and treated with alcoholic hydrochloric acid to give the corresponding 4-(o-methylaminophenoxy)-3-thiophenecarboxylic acid hydrochloride (V) and 4-(2-methylamino-p-tolyloxy)-3-thiophenecarboxylic acid hydrochloride (VI) compounds.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04239898 |
|---|
| Source dataset | uspto-grants-1980_12 |
|---|
| ORD ID | ord-671e9dca96ea48ce834f8a30b81c9120 |
|---|
| Source note | uspto-grants-1980_12 |
|---|